Molecular analysis, including oncogenic alterations (KRAS/NRAS/BRAF), mismatch repair (MMR) status, and microsatellite instability status, is recommended for mCRC according to the National Comprehensive Cancer Network (NCCN) Guidelines Version 1.2022 for colon cancer[6]. Here, BRAF is linked to malignant colon neoplasm.